Boston Scientific price target raised to $130 from $105 at Argus
Argus raised the firm’s price target on Boston Scientific (BSX) to $130 from $105 and keeps a Buy rating on the shares. The firm sees strong ...
Boston Scientific (BSX) Receives a Buy from Argus Research
Argus Research analyst David Toung maintained a Buy rating on Boston Scientific (BSX – Research Report) on February 14. The company’s shares ...
MassDevice11h
BCI maker Subsense emerges from stealth mode with $17M in seed funding
In a post on LinkedIn, Subsense announced today that it emerged from stealth mode with $17 million in seed financing.